ATR-16 syndrome
Rare chromosomal deletion causing blood disorder and intellectual disability.
ATR-16 syndrome, also known as alpha-thalassemia-intellectual disability syndrome, is a rare condition caused by the loss of a portion of one copy of chromosome 16. This disorder impacts the blood, development, and nervous system, and the specific symptoms depend on which genes are missing from the deleted segment. Because so few cases have been identified, it is hard to pin down a consistent set of core features.
People with ATR-16 have alpha-thalassemia, a blood disorder marked by lower-than-normal levels of hemoglobin and unusually small red blood cells (microcytic anemia). Affected children often show a range of distinctive physical traits, such as clubfoot, locked little fingers, a small head (microcephaly), widely spaced eyes (hypertelorism), a broad and prominent nose bridge, downward-slanting eyelid openings, small ears, a receding jaw (retrognathia), and a short neck. They also tend to have mild to moderate intellectual disabilities, delays in growth and development, and speech delays. Some children experience seizures, undescended testicles (cryptorchidism), or hypospadias.
The condition arises from a deletion at the tip of the short arm of chromosome 16, specifically from band p13.3 to the end. This deletion can result from a balanced translocation or occur spontaneously (de novo). The missing region includes the genes for hemoglobin alpha 1 (HBA1) and hemoglobin alpha 2 (HBA2).
A definitive diagnosis requires genetic testing, such as G-banded chromosome analysis, though the condition may be suspected based on the combination of symptoms. It must be distinguished from ATR-X syndrome, a very similar disorder caused by a mutation on the X chromosome, and from cases of alpha-thalassemia that happen to occur alongside intellectual disabilities without a shared genetic cause.
Treatment is tailored to each person’s symptoms. Alpha-thalassemia often resolves on its own, but some individuals may need blood transfusions or chelation therapy.
The incidence of ATR-16 syndrome is difficult to estimate, and it is likely underdiagnosed. By 2013, more than 20 cases had been described in the scientific literature.
- Field
- Medical genetics
- Known for
- Rare chromosomal deletion disorder causing alpha-thalassemia and intellectual disability
- Incidence
- More than 20 cases described as of 2013; thought to be underdiagnosed
Lore & Background
ATR-16 syndrome is caused by a deletion of part of chromosome 16, from p13.3 to the end of the chromosome. These deletions can either be due to a balanced translocation or a de novo deletion. The genes affected include hemoglobin, alpha 1 (HBA1) and hemoglobin, alpha 2 (HBA2).
Reader's Guide
ATR-16 syndrome is significant as a rare genetic disorder that links a specific chromosomal deletion to a combination of hematologic and neurodevelopmental symptoms. Its rarity and variability make it difficult to establish a definitive symptom profile, but the consistent presence of alpha-thalassemia and intellectual disability provides a diagnostic clue. The syndrome must be distinguished from ATR-X syndrome, a similar condition caused by a mutation on the X chromosome, and from unrelated cases of alpha-thalassemia with intellectual disability. Diagnosis is confirmed by genetic sequence testing, including G band analysis. Treatment depends on symptoms; alpha-thalassemia is usually self-limiting but may require blood transfusion or chelating treatment. The condition is thought to be underdiagnosed, with more than 20 cases described as of 2013.
Did You Know?
- People with ATR-16 have alpha-thalassemia, a blood disorder with less normal hemoglobin and smaller red blood cells.
- Affected children may have clubfoot, 'locked' little fingers, microcephaly, hypertelorism, and a broad, prominent nose bridge.
Frequently Asked Questions
What is ATR-16 syndrome?
ATR-16 syndrome, sometimes called alpha-thalassemia-intellectual disability syndrome, is a rare medical-genetics condition in which a segment of one chromosome 16 copy is missing. It affects the blood, brain development, and nervous system, and the exact symptom profile shifts depending on which genes fall within the deleted stretch.
What genetic change causes ATR-16 syndrome?
The disorder stems from a partial deletion on a single copy of chromosome 16, meaning one set of genes in that region is lost while the other copy remains intact. Because the missing segment can vary in size and position from patient to patient, the clinical picture is not uniform.
What are the hallmark symptoms fans and clinicians look for?
The most consistent finding is alpha-thalassemia—low hemoglobin with abnormally small red blood cells (microcytic anemia)—paired with intellectual disability. Beyond those two anchors, additional neurological or developmental features appear and disappear depending on the exact genes caught in the deletion.
How many confirmed cases of ATR-16 syndrome exist?
As of 2013, more than twenty individual cases had been described in the medical literature, making it an extremely small cohort. Most specialists believe the true number is higher because the variable presentation makes the condition easy to miss or misattribute.
Why is ATR-16 syndrome considered important in rare-disease research?
It highlights how a single chromosomal deletion can ripple across multiple organ systems—blood, brain, and development—while still evading a single diagnostic label. Its underdiagnosed status and small case pool make it a useful model for studying genotype-phenotype variability in microdeletion syndromes.
More in Rare syndromes 1-24
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced